{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-001", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 42-year-old woman with type 1 diabetes mellitus on insulin pump therapy presents with recurrent episodes of neuroglycopenia occurring 3-4 hours postprandially despite appropriate carbohydrate counting and bolus dosing. Continuous glucose monitoring shows rapid glucose drops from 180 mg/dL to 45 mg/dL within 90 minutes after meals. Gastric emptying study is normal. Anti-insulin antibodies are markedly elevated at 85% binding (normal <5%). Which mechanism best explains her hypoglycemic episodes?\nOptions:\nA. Antibody-mediated accelerated insulin clearance causing initial hyperglycemia followed by rebound hypoglycemia\nB. Antibody buffering of exogenous insulin with delayed release causing prolonged insulin action\nC. Cross-reactivity of anti-insulin antibodies with insulin receptors causing receptor activation\nD. Antibody-induced insulin resistance requiring higher doses with subsequent overdosing\nE. Complement-mediated destruction of pancreatic alpha cells reducing glucagon counterregulation\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-002", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 52-year-old woman with primary sclerosing cholangitis and ulcerative colitis presents with progressive fatigue and pruritus. Laboratory studies show alkaline phosphatase 892 U/L, total bilirubin 4.2 mg/dL, and CA 19-9 of 285 U/mL. MRCP reveals a dominant stricture at the hepatic duct bifurcation with upstream biliary dilation. Brush cytology obtained during ERCP shows atypical cells suspicious for malignancy. Fluorescence in situ hybridization (FISH) analysis demonstrates polysomy. Which additional finding on FISH would most strongly support a diagnosis of cholangiocarcinoma over reactive atypia in this clinical context?\nOptions:\nA. Homozygous deletion of 9p21 (CDKN2A/p16)\nB. Trisomy of chromosome 7\nC. Monosomy of chromosome 17\nD. Gain of chromosome 3\nE. Deletion of 1p36\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-003", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 55-year-old man with severe persistent asthma on high-dose inhaled corticosteroids, long-acting beta-agonist, long-acting muscarinic antagonist, and monthly omalizumab presents with continued poor control. Spirometry shows FEV1 45% predicted with 15% bronchodilator response. Laboratory studies reveal blood eosinophils 450 cells/\u03bcL, total IgE 850 IU/mL, and FeNO 55 ppb. Sputum analysis shows 8% eosinophils. Despite confirmed adherence and proper inhaler technique, he has had 4 exacerbations requiring systemic corticosteroids in the past year. Which biologic switch would most likely provide additional benefit?\nOptions:\nA. Dupilumab targeting IL-4 receptor alpha\nB. Benralizumab targeting IL-5 receptor alpha\nC. Mepolizumab targeting IL-5\nD. Tezepelumab targeting thymic stromal lymphopoietin\nE. Continue omalizumab with addition of low-dose oral corticosteroids\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-004", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 45-year-old woman with lupus nephritis class IV on mycophenolate mofetil and prednisone develops acute kidney injury with serum creatinine rising from 1.2 to 3.8 mg/dL over 2 weeks. Urinalysis shows 3+ protein, numerous dysmorphic RBCs, and RBC casts. Complement levels are normal and anti-dsDNA titers are stable. Kidney biopsy reveals crescentic glomerulonephritis with linear IgG staining along the glomerular basement membrane, with concurrent immune complex deposits in the mesangium. Anti-GBM antibodies are positive at 85 EU (normal <20). Which statement best characterizes this clinical entity?\nOptions:\nA. This represents lupus flare requiring intensification of immunosuppression alone\nB. The linear IgG staining is an artifact from prior immune complex deposition\nC. This is anti-GBM disease superimposed on lupus nephritis requiring plasmapheresis\nD. Concurrent ANCA-associated vasculitis is the most likely explanation\nE. The anti-GBM antibodies are false-positive due to cross-reactivity with dsDNA\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-005", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 68-year-old woman with a history of rheumatoid arthritis on methotrexate presents with progressive fatigue and spontaneous ecchymoses over 3 weeks. Laboratory studies reveal hemoglobin 7.2 g/dL, MCV 102 fL, WBC 3.8 \u00d7 10\u2079/L, platelets 142 \u00d7 10\u2079/L, reticulocyte count 0.8% (absolute 28 \u00d7 10\u2079/L), and aPTT 78 seconds (normal 25-35). Mixing study shows partial correction of aPTT to 52 seconds at time zero and 58 seconds after 2-hour incubation at 37\u00b0C. Factor VIII activity is 2%, factor IX activity is normal, and Bethesda titer is 4.2 BU/mL. She develops a large retroperitoneal hematoma requiring transfusion. Recombinant activated factor VII is initiated with initial hemostatic control. Immunosuppression with prednisone 1 mg/kg daily is started. On hospital day 5, emicizumab 3 mg/kg subcutaneously is administered as a loading dose. On hospital day 8, the patient develops acute chest pain and dyspnea. CT angiography reveals bilateral subsegmental pulmonary emboli. D-dimer is markedly elevated at 8,400 ng/mL. The aPTT remains prolonged at 72 seconds. Chromogenic factor VIII assay (human reagents) is 12%, and chromogenic factor VIII assay (bovine reagents) is 8%. Repeat Bethesda titer is 3.8 BU/mL. Which therapeutic approach is the most appropriate next step in management?\nOptions:\nA. Initiate therapeutic anticoagulation with unfractionated heparin and continue emicizumab\nB. Place an inferior vena cava filter and discontinue emicizumab\nC. Discontinue emicizumab, initiate therapeutic anticoagulation with low molecular weight heparin, and intensify immunosuppression with rituximab\nD. Continue emicizumab, place an inferior vena cava filter, and add cyclophosphamide to the immunosuppressive regimen\nE. Discontinue emicizumab, administer activated prothrombin complex concentrate for hemostatic coverage, and initiate therapeutic anticoagulation with fondaparinux\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-006", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 28-year-old woman presents with recurrent sinopulmonary infections since childhood, chronic diarrhea, and splenomegaly. Laboratory evaluation reveals IgG 180 mg/dL (normal 700-1600), IgA <7 mg/dL, IgM 320 mg/dL (normal 40-230), and absent isohemagglutinins. Flow cytometry shows normal B-cell numbers but absent CD27+ memory B cells. Genetic testing reveals a hemizygous mutation in CD40LG. Her brother has similar symptoms. Which finding would be most unexpected in this patient?\nOptions:\nA. Cryptosporidium parvum cholangiopathy\nB. Pneumocystis jirovecii pneumonia\nC. Germinal center formation on lymph node biopsy\nD. Neutropenia\nE. Elevated liver enzymes\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-007", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 29-year-old woman presents with 2 years of recurrent oral ulcers, genital ulcers, and bilateral anterior uveitis. She now develops sudden painless vision loss in her right eye. Examination reveals visual acuity of hand motion OD and 20/25 OS. Fundoscopy of the right eye shows diffuse retinal whitening with cherry-red spot and box-carring in retinal arterioles. Fluorescein angiography confirms central retinal artery occlusion. HLA-B51 is positive. Pathergy test is negative. What is the most appropriate immediate intervention to prevent contralateral involvement?\nOptions:\nA. High-dose intravenous methylprednisolone alone\nB. Infliximab infusion\nC. Combination of high-dose corticosteroids with cyclosporine\nD. Combination of high-dose corticosteroids with infliximab or adalimumab\nE. Anterior chamber paracentesis with ocular massage\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-008", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 34-year-old man from the Ohio River Valley presents with 3 weeks of fever, night sweats, and 15-pound weight loss. He has a history of HIV infection with CD4 count of 45 cells/\u03bcL and is not on antiretroviral therapy. Physical examination reveals hepatosplenomegaly and diffuse lymphadenopathy. Laboratory studies show pancytopenia and LDH 1,850 U/L. Bone marrow biopsy reveals small intracellular yeast forms within macrophages. Urine Histoplasma antigen is strongly positive. He is started on liposomal amphotericin B. On day 3 of treatment, he develops high fever, hypotension, and worsening respiratory status despite negative blood cultures and improving fungal markers. Which intervention is most appropriate?\nOptions:\nA. Add voriconazole for possible amphotericin-resistant Histoplasma\nB. Initiate corticosteroids for immune reconstitution inflammatory syndrome\nC. Switch to itraconazole due to amphotericin B toxicity\nD. Add broad-spectrum antibiotics for bacterial superinfection\nE. Delay antiretroviral therapy initiation for at least 4 weeks\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-009", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 58-year-old woman with metastatic HER2-positive breast cancer on trastuzumab deruxtecan develops progressive dyspnea over 4 weeks. CT chest reveals bilateral ground-glass opacities with a peripheral and lower lobe predominant distribution. Bronchoalveolar lavage shows lymphocytic predominance with CD4/CD8 ratio of 0.5. Infectious workup is negative. She is diagnosed with drug-induced interstitial lung disease. After drug discontinuation and corticosteroid initiation, her symptoms improve. Three months later, restaging shows disease progression. Which factor most strongly supports rechallenge with trastuzumab deruxtecan?\nOptions:\nA. Initial ILD grade was 1 with complete radiographic resolution\nB. Absence of anti-drug antibodies on serologic testing\nC. HER2 amplification ratio >6 on repeat biopsy\nD. Negative rechallenge skin testing to the drug\nE. Normal pulmonary function tests at baseline before rechallenge\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_claude-opus-4-5-20251101_p03__ABMS20260101_claude-opus-4-5-20251101_p03-010", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 42-year-old woman with a history of chronic rhinosinusitis and nasal polyps presents with new-onset asthma requiring systemic corticosteroids. She reports severe reactions to aspirin and ibuprofen characterized by bronchospasm and nasal congestion. She requires hip replacement surgery and the orthopedic surgeon requests clearance for perioperative ketorolac use. After shared decision-making, aspirin desensitization is planned. During the desensitization protocol, she develops bronchospasm at the 60 mg aspirin dose. Which mediator's urinary metabolite would be most elevated during this reaction?\nOptions:\nA. Leukotriene E4\nB. Prostaglandin D2 (as 11\u03b2-prostaglandin F2\u03b1)\nC. Histamine (as N-methylhistamine)\nD. Tryptase\nE. Platelet-activating factor\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
